RxDoctor Payments Data

Michael Baldeck, DO

Family Medicine · Lewiston, IDNPI 1669428967

Payments from drug & device makers

$461in general payments, 2019–2025

Across 23 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$214
  • Lilly USA, LLC$132
  • Novo Nordisk$41
  • AstraZeneca$33
  • GSK$27
  • Dexcom, Inc.$15

What the payments were for

  • Food & beverage$461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer13$214
Lilly USA, LLC4$132
Novo Nordisk1$41
AstraZeneca2$33
GSK2$27
Dexcom, Inc.1$15

How this compares

$461 in reported general payments places this provider in the 60th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$97,014
Medicare patients
307
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban70$58,426
EliquisApixaban62$54,472
Tresiba Flextouch U-200Insulin Degludec32$45,911
JardianceEmpagliflozin37$32,518
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$29,497
OzempicSemaglutide25$24,919
MounjaroTirzepatide20$20,270
FarxigaDapagliflozin Propanediol11$10,549
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen364$8,800
Tresiba Flextouch U-100Insulin Degludec16$7,672
Fentanyl40$6,084
Metoprolol Succinate277$5,152
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$4,520
Potassium Chloride223$4,330
Tamsulosin Hcl249$4,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$214$54,47262 claims
GSKTrelegy Ellipta$27$29,49740 claims
Novo NordiskOzempic$41$24,91925 claims
Lilly USA, LLCMounjaro$132$20,27020 claims
AstraZenecaFarxiga, Symbicort$33$13,96525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 803 family medicine providers in Idaho.

Other family medicine in Lewiston

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →